Editor Profiles

Dr Ian Martins is the Fellow of International Agency for Standards and Ratings (IASR) and the Chief Editor of the International Journal of Diabetes Research (Scientific Academic Publishing), Research and Reveiws: Neuroscience, Journal of Diabetes and Clinical Studies and is now 96 % of the RG Score (ResearchGate). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). The Scientific Reputation ranks in the last 4% of International Scientists and Researchers in the world. Dr Ian Martins is now conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM ON LINE CHAPTER/Ebook: 2015 Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic diseases and Alzheimer’s disease. Research Interest: Diabetes Metabolism Nutrition Myocardial Infarction Neurodegenerative Diseases Molecular Cell Biology Insulin Resistance Proteomics Apoptosis

Dr. María Luz Gunturiz Albarracín, is a Scientific Researcher Department of Public Health Research Division, National Institute of Health, Bogotá, Colombia,Biologist, specialist in health management, PhD in Biotechnology with experience in molecular and cellular biology of chronic diseases such as cancer and cardiovascular disease and infectious diseases (malaria, toxoplasma, giardia, dengue, zika, chikungunya, among others). Currently, from the Team Project Bank, I formulate and execute research projects incorporating several tools of molecular biology and biotechnology and support the execution of various proposals and the detection of several microorgansmos by nucleic acid sequencing. Research Interest: Chronic Noncommunicable Diseases; Diabetes; Hypertension; Obesity.

Dr. Tanawan Riangwiwat, is a Cardiology Department, Geisinger Medical Center, Danville, PA, United States of America Research Interest: Cardiovascular Revascularization Medicine

Biography: Saima Karim, DO is currently working an Associate Program Director in MetroHealth Medical Center, USA. She got Ph.D. from Yale New Haven Hospital/Yale University, New Haven, CT, USA. Research Interest: Safety of atrial fibrillation ablation Timing of atrial fibrillation ablation Safety of Novel anticoagulants in stroke prevention in special populations. Timing of atrial fibrillation ablation Racial and socioeconomic disparities in the delivery of care for Electrophysiology

Dr Burton Altura, Our laboratory is addressing two of the most important issues in vascular biology today: stroke mechanisms; and irreversible cellular destruction in the cardiovascular system caused by alcohol and substance abuse. These studies have already led to the prevention of atherosclerotic lesions, hypertension and stroke-like events in experimental animal models. Additional experimental studies, using manipulations in divalent cation metabolism, have been very effective in the prevention and amelioration of alcohol-, phencyclidine-, cocaine-, and other substance abuse-induced strokes. We are using intact animals, isolated organs, tissues and cells in culture to understand how divalent cations (Mg2+ and Ca2+), sphingolipids, lipid messengers, protein kinase C and nuclear transcription factors control normal fuctions of vascular smooth muscle cells, cardiac myocytes and several types of neuronal cells. In order to accomplish these goals, we employ various state-of-the-art techniques: NMR spectroscopy; in-vivo high-resolution TV microscopy; digital image microscopy; confocal laser scanning microscopy; culture of primary cells; Mg2+ ion-selective electrodes; mono- and polyclonal antibodies; antisense oligonucleotides; and lipid chemistry. Use of the various models and techniques has led us to hypothesize that magnesium ions can regulate voltage-, receptor-, and leak-operated membrane channels in a number of cell types and that various cellular signaling pathways, particularly isoforms of PKC and sphingolipids are turned on or off by the actions and concentrations of Mg2+ at multiple cellular sites.

Dr. Ivo Petrov, MD, PhD, FESC, FACC is Professor of cardiology at the University of Sofia. He received his postgraduate specialty of Interventional cardioangiology from the University of Buenos Aires, Argentina (2001). He is one of the pioneers of endovascular therapy in Bulgaria (actual president of the Bulgarian society of endovascular therapy). After 2001 he introduced in Bulgaria interventional treatment of carotid stenosis, ischemic stroke, aortic dissection, aortic aneurysm, coronary rotablation, percutaneous recanalization of Lerisch syndrome, renal denervation. He served as national PI in numerous scientific clinical projects. Research Interest: Interventional Cardiology, Acute Coronary Syndromes, Diseases of the aorta, Interventional Cardiology, Stroke

Dr Panagiotis E. Ioannidis is a cardiologist with expertise in the diagnosis and treatment of cardiac arrhythmias. Since 2021 he is the Director of the Heart Rhythm Center at the IASO Hospital of Athens, currently classified on official national registries as one of the top electrophysiological laboratories in Greece, dealing annually with large volumes of highly specialized and complex cases. He graduated in Medicine from the University of Athens and attained the specialty of Cardiology at the Hellenic Red Cross Hospital of Athens. He holds a Doctor of Philosophy Degree with distinction in the field of atrial fibrillation ablation from the Aristotle University of Thessaloniki, where for several years, was invited to perform the ablation procedures. From 2004 to 2006 he was a research associate in the field of cardiac electrophysiology in the Cardiology Department of Athens University at "Hippokration" Hospital. In 2006 he was a research fellow at San Raffaele Hospital in Milan. From 2007 to 2012 he worked as head of the cardiac electrophysiology team at the "Henry Dunant" Hospital. From 2012 to 2021 he was the Director of the Cardiac Electrophysiology and Pacing Department in Athens Bioclinic Hospital. Research interest: Cardiac electrophysiology, Catheter ablation, Atrial fibrillation, Atrial tachycardias, Supraventricular tachycardias, Ventricular arrhythmias-tachycardias, Pacing, ICDs, Cardiac resynchronization therapy.

Kitigon Vichairuangthum, M.D. Ph.D.FAPSIC is a graduate of Chulalongkorn University School of Medicine in Bangkok, Thailand. After graduating Dr. Kitigon completed a fellowship program in interventional cardiology at Vajira hospital, Thailand. He focused on the patient treatment in complex percutaneous coronary intervention such as bifurcation lesion and chronic total occlusion lesion for more than 10,000 patients in last 10 years. This experimental and research based approach to this fields is what Dr. Kitigon is known for throughout the medical community and his expertise continues to be sought in critical cases. Currently, Dr. Kitigon is a director of cardiovascular unit, Kluaynamthai hospital and also be a consulting cardiologist at Royal heart medical center, Hua Hin hospital. With his expertise, he has contributed his work in more than 20 international medical journals and also participate in editorial board member of Annals of Health & Medical Science and The Bangkok Medical Journal.